Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salt Replacement for Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis

NCT00163852 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.

NCT NCT00163852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00163852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salt Replacement for Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis
Lead sponsor
Bayside Health
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 29, 2004
Completion date
February 28, 2006
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis